This course is developed by Medscape Education Global. Medscape is one of the leading digital platforms for medical education. A comprehensive array of innovative formats, in multiple languages, insures the right educational solution is available to best achieve desired objectives—from text-based articles to state-of-the-art multimedia formats and the most sophisticated simulation environments. Activity formats include Clinical Insights, Expert Perspective, Instructional Series Programming, Next-Generation Symposia, Patient-Case Approaches, including Simulation and Clinical Advances.

2020's shift to virtual editions of the major scientific congresses marked a new era for communicating the results of ground breaking research in topics that affect clinical practice. This page is dedicated to updates in promising new pharmacologic agents for management of diabetes and metabolic disorders, and related conditions including non-alcholic steatohepatitis (NASH) and cardiovascular disease (CVD), from GLP-1 receptor agonists through novel insulins, to primary and secondary prevention of micro- and macrovascular complications of diabetes, and obesity management, join us for a virtual journey to these new frontiers in patient care as you listen to experts in diabetes, metabolic disorders, and CVD from across the globe discuss new data and recent publications in mature, growing, and emerging fields of diabetes care.

Made for: Gastroenterologists, Diabetoligists, Endocrinologists, Primary Care Physicians

Disease areas: Diabetes, Non-Alcoholic Steatohepatitis, Cardiovascular Disease, Chronic Kidney Disease

 Developed by: Medscape Education Global